News About: Pharm. Industry


DHP Korea acquire German EU GMP for disposable eyewashes

DHP Korea(CEO Dae-Hoon Yeo), a company specializing in disposable eyewash products, acquired the EU GMP certificate from the Federal Ministry of Health(Germany) on 18 May. The certificate means the overall manufactur...

Allergan Korea appoints Ji-Hyun Kim as new branch manager

Allergan Korea recruited CEO Ji-Hyun Kim as a new branch manager on 15 May. CEO Ji-Hyun Kim has been evaluated as a person qualified to continuously lead the growth of Allergan Korea as showing business insight and l...

1 of 3 listed pharmas with SG&A ration higher than 40%

1 of 3 listed pharmaceutical companies reportedly have a SG&A expense/sales ratio higher than 40%. Yakup Shinmoon(www.yakup.com) analyzed 2018 1st quarter business performances that 62 listed pharmaceutical companies...

Daewoong Pharmaceutical acquires cGMP approval of Nabota factory from US FDA

Daewoong Pharmaceutical(CEO Seung-Ho Jeon) received an establishment inspection report(EIR) which mentioned approval for the Nabota(prabotulinumtoxin A, DWP-450) manufacturing facility from the US Food and Drug Admini...

Celltrion Healthcare’s ‘Herzuma’ had first prescription in Germany

‘Herzuma(generic name: trastuzumab),’ an antibody biosimilar for the treatment of breast cancer and stomach cancer, Celltrion Healthcare is actively selling in the world had the first prescription in Germany as it did...

Samil Pharmaceutical signs co-sales agreement of ‘Lastacaft Soln’ with Allergan

Samil Pharmaceutical(CEO Seung-Beom Huh) announced on 14 Mary that the company signed a distribution and co-sales agreement of Lastacaft Ophthalmic Solution 0.25% 5mL(alcaftadine), an allergic conjunctivitis therapy, ...

1st group of the pharma industry to complete ‘ISO 37001’ process by this June

The ‘ISO 37001’ certification program that the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) decided to take to raise the Korean pharmaceutical companies’ ethical management into the global leve...

Phase IV clinical trial result of Shin Poong Pharm’s Pyramax announced at conference in Africa

In the Satellite symposium at the Pan African Malaria Conference – Multilateral Initiatives on Malaria(MM) at Dakar, Senegal, Shin Poong Pharm(CEO Jae-Man Yoo) announced the Pyramax’s clinical trial result. Held arou...

Pharmbio Korea signs exclusive license agreement of new opioid painkiller with U.S.

Pharmbio Korea(Chairman Bong-Gil Nam) announced on the 14th that the company signed an exclusive license agreement for development and commercialization of Oliceridine, an opioid, intravenous injection being developed...

“Korean pharma industry must put more strength into commercialization to enter global market”

It was criticized the Korean pharmaceutical industry needed localized commercialization and partnership as things to improve when entering the global market. Tim Reiner, Business Development Head at Mundi Pharma, dia...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.